← Back to Search

Whole Body Non-Contrast MRI for Prostate Cancer

N/A

Waitlist Available

Led By Michael E Hahn, MD

Research Sponsored by University of California, San Diego

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 15 months

Awards & highlights

Study Summary

This trial is testing whether improved MRI technology can help doctors better find and describe tumors in patients with prostate cancer, without needing to inject them with a contrast dye.

Eligible Conditions

Prostate Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 15 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~15 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 15 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Covariance of Whole Body MRI Cellularity Index (CI) and PET/CT Standardized Uptake Value (SUV)

Specificity and Sensitivity of Whole Body MRI in Relation to Standard-of-Care Imaging

Trial Design

1Treatment groups

Experimental Treatment

Group I: Whole Body Non-Contrast MRIExperimental Treatment1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor

1,120 Previous Clinical Trials

1,521,257 Total Patients Enrolled

6 Trials studying Prostate Cancer

1,120 Patients Enrolled for Prostate Cancer

Prostate Cancer FoundationOTHER

47 Previous Clinical Trials

2,630 Total Patients Enrolled

27 Trials studying Prostate Cancer

1,780 Patients Enrolled for Prostate Cancer

United States Department of DefenseFED

861 Previous Clinical Trials

227,044 Total Patients Enrolled

38 Trials studying Prostate Cancer

9,054 Patients Enrolled for Prostate Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants have joined in this clinical investigation?

"Confirmed. The clinical trial is actively recruiting as documented on clinicaltrials.gov; it was first posted in March 2016 and revised last April 2021, with an objective of enrolling 150 patients at a single site."

Answered by AI